CRASH-3 (Trial) Lancet 2019 – Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial The CRASH-3 trial collaborators† Show footnotesOpen AccessPublished:October 14, 2019DOI:https://doi.org/10.1016/S0140-6736(19)32233-0 Leia mais »
Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications Leia mais »
Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes. Leia mais »
Stereotactic Radiosurgery favorably changes the clinical course of hemangioblastoma growth in von Hippel-Lindau and sporadic patients. Leia mais »
Posterior Fossa Decompression With or Without Duraplasty in the Treatment of Paediatric Chiari Malformation Type I: A Literature Review and Meta-Analysis. Leia mais »
Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues. Leia mais »